oxyphenbutazone has been researched along with Lock Jaw in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dieckmann, J | 1 |
| Breytenbach, HS | 1 |
1 trial available for oxyphenbutazone and Lock Jaw
| Article | Year |
|---|---|
[Possibilities for pain reduction by the prevention of edemas and elimination of endogenous pain producing substances].
Topics: Apicoectomy; Coumarins; Drug Combinations; Edema; Humans; Hydroxyethylrutoside; Maxillary Sinus; Noc | 1978 |
1 other study available for oxyphenbutazone and Lock Jaw
| Article | Year |
|---|---|
Effects of tanderil (oxyphenbutazone), chymoral (proteolytic enzymes) and placebo in the control of swelling, trismus and pain after the removal of impacted wisdom teeth.
Topics: Female; Humans; Male; Molar; Oxyphenbutazone; Pain, Postoperative; Peptide Hydrolases; Placebos; Pos | 1976 |